Correlation Between Cooper Companies, and Haemonetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cooper Companies, and Haemonetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cooper Companies, and Haemonetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Cooper Companies, and Haemonetics, you can compare the effects of market volatilities on Cooper Companies, and Haemonetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cooper Companies, with a short position of Haemonetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cooper Companies, and Haemonetics.

Diversification Opportunities for Cooper Companies, and Haemonetics

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cooper and Haemonetics is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding The Cooper Companies, and Haemonetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Haemonetics and Cooper Companies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Cooper Companies, are associated (or correlated) with Haemonetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Haemonetics has no effect on the direction of Cooper Companies, i.e., Cooper Companies, and Haemonetics go up and down completely randomly.

Pair Corralation between Cooper Companies, and Haemonetics

Considering the 90-day investment horizon The Cooper Companies, is expected to under-perform the Haemonetics. But the stock apears to be less risky and, when comparing its historical volatility, The Cooper Companies, is 3.22 times less risky than Haemonetics. The stock trades about -0.23 of its potential returns per unit of risk. The Haemonetics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  7,329  in Haemonetics on August 24, 2024 and sell it today you would earn a total of  1,214  from holding Haemonetics or generate 16.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

The Cooper Companies,  vs.  Haemonetics

 Performance 
       Timeline  
Cooper Companies, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in The Cooper Companies, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Cooper Companies, may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Haemonetics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Haemonetics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Haemonetics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Cooper Companies, and Haemonetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cooper Companies, and Haemonetics

The main advantage of trading using opposite Cooper Companies, and Haemonetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cooper Companies, position performs unexpectedly, Haemonetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Haemonetics will offset losses from the drop in Haemonetics' long position.
The idea behind The Cooper Companies, and Haemonetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Correlations
Find global opportunities by holding instruments from different markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences